Administrative Core

摘要 行政核心(ADM)将作为我们第三阶段Cobre的全面监督能力发挥作用。它是 由指导委员会、外部和内部咨询委员会以及其他利益攸关方组成。《行政管理》 CORE将由文斯·卡尔霍恩博士指导，他是目前提案的PI。它还将在 监督备受尊敬的精神病学临床医生兼研究员Juan Bustillo博士和Nora Perrone-Bizzoero博士，以及 著名的神经学家和教育家。医学博士杰夫·利伯曼和医学博士查尔斯·鲍登将担任 外部顾问。核心主任将协调行政管理核心的职责和目标，重点是三个目标： 1)协调三个技术核心所需的所有具体预算、管理和人事方面 和试点项目计划；2)建立强有力的社区外展计划，支持新的调查项目 使用我们的试点项目核心；以及3)维护并继续开发重要的核心设施，与 内部和外部顾问。此第三阶段奖励的长期目标是扩大我们设施的能力 进一步发展多元化的神经影像研究环境，将继续具有竞争力 国内和国际上。我们相信，通过科布雷第三阶段的支持，我们的凝聚力和 跨学科和转化性研究的协作计划可用于中心级拨款(例如，P41， P50)，将在第三阶段授标开始后大约3年提交。因此，这一阶段三 获奖对我们新墨西哥州神经精神疾病多模式成像项目的全面成功至关重要 生病了。

Abstract The administrative core (ADM) will function in an overall supervisory capacity for our Phase III COBRE. It is comprised of a steering committee, external and internal advisory committees, and other stakeholders. The ADM core will be directed by Dr. Vince Calhoun, the PI for the current proposal. It will also operate under the supervision of a well-respected psychiatric clinician-researcher, Dr. Juan Bustillo, and Dr. Nora Perrone-Bizzozero, an established neuroscientist and educator. Drs. Jeff Lieberman, MD and Charles Bowden, MD will serve as external consultants. The core director will coordinate the duties and goals of the ADM core, focused on three aims: 1) to coordinate all the specific budgetary, regulatory, and personnel aspects required in the three technical cores and Pilot Project Program; 2) set up a strong community outreach program and support new investigator projects using our pilot project core; and 3) maintain and continue to develop vital core facilities in consultation with internal and external advisors. A long-term aim of this Phase III award is to expand the capability of our facilities and further develop a diversified neuroimaging research environment that will continue to be competitive nationally and internationally. We believe that through the support of a COBRE Phase III, our cohesive and collaborative program of interdisciplinary and translational research can be leveraged into a center-level grant (e.g. P41, P50) which will be submitted approximately 3 years after the start of the Phase III award. Hence, this Phase III award is essential for the overall success of our New Mexico program on multimodal imaging of neuropsychiatric illness.